# Switching From Preserved to Preserved-free Treatments for Glaucoma.

> **NCT01433900** · PHASE3 · UNKNOWN · sponsor: **Paolo Fogagnolo** · enrollment: 40 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Tafluprost
- **DRUG:** Latanoprost

## Key facts

- **NCT ID:** NCT01433900
- **Lead sponsor:** Paolo Fogagnolo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2013-05
- **Final completion:** 2014-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01433900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01433900, "Switching From Preserved to Preserved-free Treatments for Glaucoma.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01433900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*